Pfizer (PFE) Q2 2017 Results - Earnings Call Transcript

8/2/17

Pfizer Inc. (NYSE:PFE)

Q2 2017 Earnings Call

August 01, 2017 10:00 am ET

Executives

Charles E. Triano - Pfizer Inc.

Ian C. Read - Pfizer Inc.

Frank A. D'Amelio - Pfizer Inc.

John D. Young - Pfizer Inc.

Albert Bourla - Pfizer Inc.

Mikael Dolsten - Pfizer Inc.

Analysts

Gregg Gilbert - Deutsche Bank Securities, Inc.

Jami Rubin - Goldman Sachs & Co. LLC

Alex Arfaei - BMO Capital Markets (United States)

Christopher T. Schott - JPMorgan Securities LLC

Jeffrey Holford - Jefferies LLC

Umer Raffat - Evercore Group LLC

David Maris - Wells Fargo Securities LLC

John T. Boris - SunTrust Robinson Humphrey, Inc.

Timothy Minton Anderson - Sanford C. Bernstein & Co. LLC

Richard J. Purkiss - Piper Jaffray Ltd.

Geoffrey Meacham - Barclays Capital, Inc.

Marc Goodman - UBS Securities LLC

Tony Butler - Guggenheim Securities LLC

David R. Risinger - Morgan Stanley & Co. LLC

Operator

Good day, everyone, and welcome to Pfizer's second quarter 2017 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.